欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

您的位置 : 首页  /  MAPK/ERK Pathway  /  Raf  /  Tovorafenib

CAS No.: 1096708-71-2

Tovorafenib Catalog No. CSN13788

Synonyms: TAK-580;MLN 2480;BIIB-024

MLN 2480 is a selective inhibitor of pan-Raf kinase with antitumor activity.

规格 价格 促销价格 库存 数量
纯度 & 质量文件 批次:

靶点选择性

生物活性

  • 描述
  • 动物研究
    剂量

    Mice: 12.5 mg/kg[2] (p.o.), 30 mg/kg[3] (p.o.)

    给药途径

    p.o.

  • 临床研究
  • NCT号适应症或疾病临床期招募状态预计完成时间地点
    NCT02723006MelanomaPhase 1Terminated(Business decision P... more >>rotocol efficacy futility met) Collapse <<-United States, Arizona ... more >> University of Arizona Cancer Center Tucson, Arizona, United States United States, California University of California Los Angeles - Jonsson Comprehensive Cancer Center Los Angeles, California, United States University of California San Francisco Medical Center San Francisco, California, United States United States, Colorado University of Colorado Cancer Center Aurora, Colorado, United States United States, Georgia Emory University Hospital Atlanta, Georgia, United States United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States United States, Minnesota Virginia Piper Cancer Institute Minneapolis, Minnesota, United States United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States United States, New York New York University Langone Medical Center New York, New York, United States United States, Pennsylvania Saint Luke's Cancer Center - Bethlehem Easton, Pennsylvania, United States Fox Chase Cancer Center Philadelphia, Pennsylvania, United States United States, Texas Texas Oncology-Baylor Charles A. Sammons Cancer Center Dallas, Texas, United States United States, Virginia Inova Fairfax Hospital Fairfax, Virginia, United States Collapse <<
    NCT02327169Advanced Nonhematologic Malign... more >>ancies Collapse <<Phase 1Completed-United States, Massachusetts ... more >> Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 2114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 2115 Dana Farber Cancer Institute Boston, Massachusetts, United States, 2115 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Texas The University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 France Institut Bergonie Bordeaux cedex, Gironde, France, 33076 Institut Claudius Regaud-Oncopole Toulouse cedex 09, Haute Garonne, France, 31059 Institut Gustave Roussy Villejuif cedex, Val De Marne, France, 94805 Spain Hospital Universitari Vall d'Hebron Barcelona, Spain, 8035 START Madrid. Fundacion Jimenez Diaz Madrid, Spain, 28040 Hospital Clinico Universitario Virgen de la Victoria Malaga, Spain, 29010 United Kingdom Sarah Cannon Research Institure UK London, Greater London, United Kingdom, W1G 6AD The Chrisie Manchester, Greater Manchester, United Kingdom, M20 4BX Churchill Hospital Oxford, Oxfordshire, United Kingdom, OX3 7LJ Collapse <<
    NCT01425008Melanoma Meta... more >>static Melanoma Solid Tumor Collapse <<Phase 1Completed-United States, California ... more >> San Francisco, California, United States United States, Colorado Denver, Colorado, United States United States, Georgia Augusta, Georgia, United States United States, Indiana Indianapolis, Indiana, United States United States, New York New York, New York, United States United States, Pennsylvania Easton, Pennsylvania, United States Philadelphia, Pennsylvania, United States United States, Texas San Antonio, Texas, United States United States, Washington Lakewood, Washington, United States United Kingdom Bristol, Avon, United Kingdom Cambridge, Cambridgeshire, United Kingdom Chelmsford, Essex, United Kingdom London, Greater London, United Kingdom Manchester, Greater Manchester, United Kingdom Oxford, Oxfordshire, United Kingdom Newcastle upon Tyne, Tyne & Wear, United Kingdom Collapse <<
  • 更多
  • 参考文献

实验方案

技术信息

CAS号 1096708-71-2 储存条件
分子式 C17H12Cl2F3N7O2S 运输 蓝冰
分子量 506.29 别名 TAK-580;MLN 2480;BIIB-024;BUB-024
溶解度
DMSO50.0 mg/mL (98.8 mM)
Waterinsoluble
动物实验配方

大规格询价

号为必填项

姓名: 邮箱: 手机号:
留言:
   提交
联系
我们